HYA Advisors’s iShares Biotechnology ETF IBB Stock Holding History

HYA Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$290K	Sell	2,466 -250	-9%	-$29.7K	0.11%	117
2022 Q1	$354K	Buy	2,716 +2	+0.1%	+$261	0.12%	114
2021 Q4	$414K	Sell	2,714 -546	-17%	-$84.5K	0.15%	101
2021 Q3	$504K	Buy	3,260 +109	+3%	+$18.3K	0.2%	82
2021 Q2	$516K	Sell	3,151 -169	-5%	-$26K	0.22%	75
2021 Q1	$500K	Buy	3,320 +2	+0.1%	+$318	0.24%	74
2020 Q4	$503K	Buy	3,318 +1	+0%	+$143	0.27%	66
2020 Q3	$449K	Buy	3,317 +1	+0%	+$136	0.27%	61
2020 Q2	$453K	Buy	3,316 +252	+8%	+$32.1K	0.3%	58
2020 Q1	$330K	Buy	3,064 +519	+20%	+$59.8K	0.27%	71
2019 Q4	$307K	Buy	+2,545	New	+$284K	0.2%	84

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

HYA Advisors's IBB Position: Q2 2022 in Review

HYA Advisors reduced its iShares Biotechnology ETF (IBB) stake by 9.2% in Q2 2022, selling an estimated $29.7K and leaving 2,466 shares worth $290K. The position accounts for 0.11% of the portfolio, ranked #117.

HYA Advisors first reported a position in IBB in Q4 2019 and has held it in 11 quarters since. The position peaked at $516K in Q2 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

HYA Advisors held 2,466 shares of iShares Biotechnology ETF worth $290K as of Q2 2022.
HYA Advisors sold 250 iShares Biotechnology ETF shares in Q2 2022, an estimated $29.7K.
iShares Biotechnology ETF made up 0.11% of HYA Advisors's portfolio in Q2 2022, its #117 holding.
HYA Advisors first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 11 quarters since.
HYA Advisors's iShares Biotechnology ETF position peaked at $516K in Q2 2021.
858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on HYA Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.